Background The effect of obstructive sleep apnoea-hypopnoea as a cardiovascular risk
factor and the potential protective effect of its treatment with continuous positive airway …

Obstructive sleep apnoea (OSA) is a common health concern caused by repeated episodes
of collapse of the upper airway during sleep. The events associated with OSA lead to brain …

Background Obstructive sleep apnoea is associated with raised blood pressure. If blood
pressure can be reduced by nasal continuous positive airway pressure (nCPAP), such …

Background Obstructive sleep apnea is associated with an increased risk of cardiovascular
events; whether treatment with continuous positive airway pressure (CPAP) prevents major …

Background Studies have reported inconsistent findings regarding the association between
obstructive sleep apnea (OSA) and future risks of cardiovascular and all-cause mortality. We …

Background and objective The objective of this study was to evaluate the long‐term
cardiovascular mortality in patients with severe obstructive sleep apnoea (OSA) treated with …

Background Obstructive sleep apnea syndrome (OSAS) has been associated with increased
morbidity and mortality, principally from cardiovascular disease, but the impact of nasal …

Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients
with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with …

Purpose The associations between obstructive sleep apnea (OSA) and all-cause and
cardiovascular mortality are well established but are not entirely consistent. To accurately …

Obstructive sleep apnoea (OSA) is a common disorder in which repetitive apnoeas expose
the cardiovascular system to cycles of hypoxia, exaggerated negative intrathoracic pressure …